How Do Type 2 Diabetes Mellitus-Related Chronic Complications Impact Direct Medical Cost in Four Major Cities of Urban China?

Wang, Weibing; Fu, Chaowei; Pan, Chang Yu; Chen, Weiqing; Zhan, Siyan; Luan, Rongsheng; Tan, A. T. H.; Liu, Zhaolan; Xu, Biao

doi:10.1111/j.1524-4733.2009.00561.x

Cited by 57 publications

(51 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our study showed that DM cost increased with the number of complications. This result underlines the evidence from other studies showing that complication-induced direct medical cost causes a high economic burden in diabetic patients [22, 27]. The longitudinal data showed a significant growth of percentage of patient with at least one complication.…”

Section: Discussionsupporting

confidence: 84%

Economic Burden in Chinese Patients with Diabetes Mellitus Using Electronic Insurance Claims Data

et al. 2016

View full text Add to dashboard Cite

BackgroundThere is a paucity of studies that focus on the economic burden in daily care in China using electronic health data. The aim of this study is to describe the development of the economic burden of diabetic patients in a sample city in China from 2009 to 2011 using electronic data of patients’ claims records.MethodsThis study is a retrospective, longitudinal study in an open cohort of Chinese patients with diabetes. The patient population consisted of people living in a provincial capital city in east China, covered by the provincial urban employee basic medical insurance (UEBMI). We included any patient who had at least one explicit diabetes diagnosis or received blood glucose lowering medication in at least one registered outpatient visit or hospitalization during a calendar year in the years 2009–2011. Cross-sectional descriptions of different types of costs, prevalence of diabetic complications and related diseases, medication use were performed for each year separately and differences between three years were compared using a chi-square test or the non-parametric Kruskal-Wallis H test.ResultsOur results showed an increasing trend in total medical cost (from 2,383 to 2,780 USD, p = 0.032) and diabetes related cost (from 1,655 to 1,857 USD) for those diabetic patients during the study period. The diabetes related economic burden was significantly related to the prevalence of complications and related diseases (p<0.001). The overall medication cost during diabetes related visits also increased (from 1,335 to 1,383 USD, p = 0.021). But the use pattern and cost of diabetes-related medication did not show significant changes during the study period.ConclusionThe economic burden of diabetes increased significantly in urban China. It is important to improve the prevention and treatment of diabetes to contribute to the sustainability of the Chinese health-care system.

show abstract

Section: Discussionsupporting

confidence: 84%

Economic Burden in Chinese Patients with Diabetes Mellitus Using Electronic Insurance Claims Data

et al. 2016

View full text Add to dashboard Cite

show abstract

“…Using China, an upper-middle income country, as an example, population-level primary prevention of diabetes- through media campaigns- costs well under one USD per capita per year. However, treatment of uncomplicated diabetes costs nearly 1000USD and treatment of complicated diabetes costs nearly 2,500USD [26,27]. …”

Section: Reviewmentioning

confidence: 99%

Looking at non-communicable diseases in Uganda through a local lens: an analysis using locally derived data

et al. 2014

View full text Add to dashboard Cite

The demographic and nutritional transitions taking place in Uganda, just as in other low- and middle-income countries (LMIC), are leading to accelerating growth of chronic, non-communicable diseases (NCDs). Though still sparse, locally derived data on NCDs in Uganda has increased greatly over the past five years and will soon be bolstered by the first nationally representative data set on NCDs. Using these available local data, we describe the landscape of the globally recognized major NCDs- cardiovascular disease, diabetes, cancer, and chronic respiratory disease- and closely examine what is known about other locally important chronic conditions. For example, mental health disorders, spawned by an extended civil war, and highly prevalent NCD risk factors such as excessive alcohol intake and road traffic accidents, warrant special attention in Uganda. Additionally, we explore public sector capacity to tackle NCDs, including Ministry of Health NCD financing and health facility and healthcare worker preparedness. Finally, we describe a number of promising initiatives that are addressing the Ugandan NCD epidemic. These include multi-sector partnerships focused on capacity building and health systems strengthening; a model civil society collaboration leading a regional coalition; and a novel alliance of parliamentarians lobbying for NCD policy. Lessons learned from the ongoing Ugandan experience will inform other LMIC, especially in sub-Saharan Africa, as they restructure their health systems to address the growing NCD epidemic.

show abstract

“…8 , 9 Several large clinical trials have demonstrated that tight blood glucose control correlates with a reduction in the microvascular complications of diabetes. 10 The American Diabetes Association (ADA) has designated HbA1C level of <7% as a goal of optimal blood glucose control 11 and the American Association of clinical endocrinologists has further recommended HbA1C levels of <6.5%.…”

Section: Introductionmentioning

confidence: 99%

Prevalence of microvascular complications in newly diagnosed patients with Type 2 diabetes

et al. 2013

View full text Add to dashboard Cite

Background & Objective: Microvascular complications are the major outcome of type 2 Diabetes Mellitus progression, which reduce the quality of life, incur heavy economic burdens to the health care system and increase diabetic mortality. The aims of this study were to assess the prevalence of microvascular complications among newly diagnosed type 2 diabetic patients and to analyze the association between these complications and poor glycemic control. Methods: This cross sectional hospital based study was carried out in Diabetic Clinic of Shaikh Zayed Postgraduate Medical Institute, Lahore Pakistan. The study was conducted from November 2011 to November 2012 among newly diagnosed type 2 diabetic patients. Relevant information of all patients was recorded with the help of a proforma. They were investigated for retinopathy, nephropathy and neuropathy. Results: We have divided the patients into two groups: Group I with good glycemic control (HbA1c <6.5) and group II with poor glycemic control (HbA1c >6.5). In group II microvascular complications were 89.8%. Neuropathy, nephropathy and retinopathy were present in 68.5%, 56.2% and 31.4% respectively. These similar percentages in Group I were 50%, 0% and 31% respectively and are significantly lower. Conclusion: The study showed that even in newly diagnosed type 2 diabetic patients who had poor glycemic control, frequency of microvascular complications is much higher as compared to those who had average glycemic control. Thus tight glycemic control does count even in newly diagnosed type 2 diabetics to prevent and minimize the occurrence of complications.

show abstract

How Do Type 2 Diabetes Mellitus-Related Chronic Complications Impact Direct Medical Cost in Four Major Cities of Urban China?

Cited by 57 publications

References 18 publications

Economic Burden in Chinese Patients with Diabetes Mellitus Using Electronic Insurance Claims Data

Economic Burden in Chinese Patients with Diabetes Mellitus Using Electronic Insurance Claims Data

Looking at non-communicable diseases in Uganda through a local lens: an analysis using locally derived data

Prevalence of microvascular complications in newly diagnosed patients with Type 2 diabetes

Contact Info

Product

Resources

About